Related Experiment Video
Updated: Aug 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions
Gordon E Pate1, Robert Lowe, Arun Kuchela
1Division of Cardiology, St. Paul's Hospital and Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Insights
The X-Sizer thrombectomy device improved blood flow in patients with angiographic thrombus. However, careful use is advised, especially for in-stent thrombosis, as it may not prevent distal embolization.
Area of Science:
- Interventional Cardiology
- Vascular Surgery
Background:
- Angiographic thrombus presence correlates with adverse procedural and clinical outcomes.
- Thrombectomy devices aim to improve outcomes by removing thrombus.
- The X-Sizer thrombectomy device is evaluated for its efficacy and safety.
Purpose of the Study:
- To report the clinical experience with the X-Sizer thrombectomy device.
- To assess the device's effectiveness in improving blood flow (TIMI flow).
- To identify complications associated with X-Sizer thrombectomy.
Main Methods:
- Retrospective review of 44 patients treated with the X-Sizer device from March 2001 to December 2002.
- Indications included myocardial infarction, unstable angina, and stent thrombosis.
- Procedural success, TIMI flow changes, and complications were recorded.
Main Results:
- Successful deployment in 42 out of 44 patients.
- Median TIMI flow improved from 1 to 2 post-thrombectomy (P=0.01), with a median final TIMI flow of 3.
- Complications included distal macro-embolization (4) and transient no-reflow (5). Difficulty was noted in treating in-stent thrombosis.
Conclusions:
- The X-Sizer thrombectomy device can effectively improve TIMI flow.
- The device is associated with potential complications, including distal embolization.
- Caution is warranted when using the X-Sizer device for in-stent thrombosis.
Abstract:
Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care

